|
|
|
Corporate Profile: PeptiVir
| Summary: |
PeptiVir is an early stage biopharmaceutical company focused on the development and commercialization of a conformationally constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases.
|
| Address (HQ): |
12635 East Montview Boulevard
Suite 127
Aurora, CO 80045 |
| Phone #'s (HQ): |
| Main |
(720) 859-4046 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(720) 859-4044 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
